Results 171 to 180 of about 85,967 (221)

Haemophagocytic lymphohistiocytosis in critically ill adults: a single-centre retrospective ICU cohort study. [PDF]

open access: yesFront Med (Lausanne)
Haar M   +10 more
europepmc   +1 more source

Co-expression of CD30 and SLFN11 serves as a dual biomarker for the treatment of cutaneous T-cell lymphoma. [PDF]

open access: yesNAR Cancer
Shimauchi T   +6 more
europepmc   +1 more source

nCD64 index as a new early predictive biomarker for macrophage activation syndrome in adult-onset still's disease. [PDF]

open access: yesArthritis Res Ther
Wu T   +10 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

sIL-2R levels predict the spontaneous remission in sarcoidosis.

Respiratory Medicine, 2020
Sarcoidosis is associated with a wide range of disease outcomes including spontaneous remission and progressive courses. It is necessary to identify patients with spontaneous remission without corticosteroid treatment. This study aimed to identify the markers for predicting spontaneous remission in patients with sarcoidosis.453 patients diagnosed with ...
Ying Zhou   +4 more
semanticscholar   +3 more sources

Soluble Interleukin-2 Receptor (sIL-2r) Level is a Limited Test for the Diagnosis of Adult Secondary Hemophagocytic Lymphohistiocytosis (HLH).

European Journal of Haematology, 2020
BACKGROUND Soluble interleukin-2 receptor (sIL-2r) level is used as a diagnostic tool in hemophagocytic lymphohistiocytosis (HLH). However, evidence supporting its use among adults is inadequate. OBJECTIVE AND METHODS We conducted a retrospective study
L. Naymagon   +3 more
semanticscholar   +1 more source

709 Colon cancer: SIL-2R and correlated mechanisms

European Journal of Cancer, 1995
The current research has still not clarified why serum levels of sIL-2R increase in cancer patients. In order to establish whether this could be an independent event or there are correlated mechanisms, in colon cancer patients and controls we examined the level of this soluble receptor in correlation with phenotype of PBMC; serum levels of IL-6, TNF-α,
A.M. Berghella   +7 more
openaire   +1 more source

Clinical implication of serum sIL-2R levels in ovarian cancer

Current Medical Science, 1998
The levels of serum soluble interleukin-2 receptor (sIL-2R) of 36 patients with ovarian cancer, 34 with benign gynecological tumors and 31 blood donors were measured by ELISA. Compared to those of benign and normal controls, serum levels of sIL-2R in patients with ovarian cancer elevated significantly (P < 0.01). Serum sIL-2R levels were likely related
S, Wang, G, Cai, Y, Lu
openaire   +2 more sources

Serum TNF-α, sCD8 and sIL-2R levels in childhood tuberculosis

Infection, 1995
In this study we have determined the serum tumor necrosis factor-alpha (TNF-alpha), soluble CD8 (sCD8) and soluble interleukin-2 receptor (sIL-2R) levels in children with active pulmonary tuberculosis (n = 66) and healthy controls (n = 20). Measurable serum TNF-alpha levels were detected in nine of 86 children (10.5%), all of whom belonged to the group
I B, Barlan   +4 more
openaire   +2 more sources

Soluble interleukin 2 receptor (sIL‐2R) levels in renal transplant recipients

Clinical Transplantation, 2004
Abstract:  Background:  Allograft rejection is associated with T cell activation. T cell activation leads to secretion of soluble IL‐2 receptor and elevated serum soluble IL‐2 receptor (sIL‐2R) levels. However, the clinical implication of individual elevated sIL‐2 receptor levels is unclear. We followed levels of sIL‐2R pre‐ and post‐transplantation to
Rajil, Mehta   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy